Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
By: Louise E Crowley, Andrew Wilson, David R Thickett
We’re delighted to announce that a letter highlighting the clinical need and importance of the TIPAL trial, titled Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?, has now been published in the American Journal of Respiratory and Critical Care Medicine.
Congratulations to authors Louise E Crowley, Andrew Wilson and David R Thickett!
Related Articles
‘Radical’ shift needed in child safeguarding reviews
New research involving the University of East Anglia shows that a different approach to ‘learning’ and improved infrastructure could make child safeguarding reviews more useful.
Read more
Specialist nurse wins national award for innovative diabetes care research
Andrea Lake, a diabetes specialist nurse and PhD student has won a national award in recognition of her research, which could shorten hospital stays for people with diabetes.
Read more
Mental health law changes could put autistic people at risk
Proposed reforms to the Mental Health Act (MHA) in England and Wales could inadvertently strip vital protections from autistic people and those with learning disabilities – according to UEA experts.
Read more